Open Recommendations
Recommendation Number | Significant Recommendation | Recommended Questioned Costs | Recommended Funds for Better Use | Additional Details | |
---|---|---|---|---|---|
23-E-07-003.02 | No | $0 | $0 | ||
CMS should use data to identify nursing homes or nursing home characteristics that are associated with a higher use of psychotropic drugs and focus oversight on nursing homes in which trends may signal inappropriate use. | |||||
23-E-07-003.03 | No | $0 | $0 | ||
CMS should expand the required data elements on Medicare Part D claims to include a diagnosis code. | |||||
23-E-07-003.01 | No | $0 | $0 | ||
CMS should evaluate the use of psychotropic drugs among nursing home residents to determine whether additional action is needed to ensure that use among residents is appropriate. |